Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04489095 · ClinicalTrials.gov registry record · NA
Conduction Disease After Transcatheter Aortic Valve Replacement
A NA study, sponsored by Henry Ford Health System.
- Completed
- Registry status
- NA
- Development phase
- 126
- Enrollment target
NCT04489095 is a NA study that has completed, run by Henry Ford Health System. The registered enrollment target is 126 participants.
The verdict
NCT04489095, a NA study, has completed, sponsored by Henry Ford Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 126 participants
- Enrollment target
Study Summary
This is a prospective single center Cardiology department observational study. The study aim is to better understand the predictors of high grade conduction abnormalities associated with TAVR such that a more robust evidence-based and universal strategy to manage cardiac conduction disturbances in these patients, which has been elusive, can be developed.
Interventions
- DIAGNOSTIC_TEST Electrophysiology Study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2020-07-16 |
| Est. Completion | 2022-08-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04489095
The ClinicalTrials.gov registry entry for NCT04489095 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Henry Ford Health System, which has 234 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electrophysiology Study is the first listed.
NCT04489095 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04489095 about?
NCT04489095 is a clinical study titled "Conduction Disease After Transcatheter Aortic Valve Replacement". This is a prospective single center Cardiology department observational study. The study aim is to better understand the predictors of high grade conduction abnormalities associated with TAVR such that a more robust evidence-based and universal strategy to manage cardiac conduction disturbances in t...
What is the current status of trial NCT04489095?
This trial is currently completed. It is a NA study. The enrollment target is 126 participants. The study started on 2020-07-16. Estimated completion is 2022-08-01.
What interventions are being tested in trial NCT04489095?
The interventions under investigation include: Electrophysiology Study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04489095?
This trial is sponsored by Henry Ford Health System, which has 234 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.